The global recombinant vaccines market size was valued at USD 11,507.3 million in 2021 and is poised to grow at a significant CAGR of 5.3% during the forecast period 2022-28. Increased prevalence of infectious diseases and increased technological advancements boost the growth of the recombinant vaccine market. Furthermore, increased regulatory approvals of recombinant vaccines also drive the...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian